Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT01674140
Protocol Number
NGDC-009
Phase
III
Management Group
Northeast Georgia Diagnostic Clinic
Oncology Group
Breast Oncology Group
Disease Sites
Breast
Sponsor Protocol
S1207
Principal Investigator
Charles Nash
Scope
National
Participating Institutions
Northside Hospital Diagnostic Clinic
Drugs Involved
Everolimus
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us